These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22293488)

  • 21. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging of the phase separation in mixed preparations of moisturizing cream and steroid ointment after centrifugation.
    Onuki Y; Funatani C; Yokawa T; Yamamoto Y; Fukami T; Koide T; Obata Y; Takayama K
    Chem Pharm Bull (Tokyo); 2015; 63(5):377-83. PubMed ID: 25948331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation of four types of coenzyme Q10/gamma-cyclodextrin supramolecular complexes and comparison of their pharmaceutical properties.
    Higashi T; Nishimura K; Yoshimatsu A; Ikeda H; Arima K; Motoyama K; Hirayama F; Uekama K; Arima H
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):965-70. PubMed ID: 19721257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical attributes and dissolution testing of ophthalmic ointments.
    Bao Q; Jog R; Shen J; Newman B; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2017 May; 523(1):310-319. PubMed ID: 28344172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The liberation of drugs from suspension ointments. 7. In vitro release of prednisolone from various ointment bases].
    Horsch W; Kögel J; Nitzsche R; Kretzschmann U
    Pharmazie; 1975 Nov; 30(11):724-8. PubMed ID: 1219773
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmaceutical evaluation of steroidal ointments by ATR-IR chemical imaging: distribution of active and inactive pharmaceutical ingredients.
    Yamamoto Y; Fukami T; Koide T; Suzuki T; Hiyama Y; Tomono K
    Int J Pharm; 2012 Apr; 426(1-2):54-60. PubMed ID: 22286017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension.
    Bessonova J; Meyer-Lindenberg A; Bäumer W; Kietzmann M
    Vet Ophthalmol; 2011 Mar; 14(2):109-13. PubMed ID: 21366826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liberation of hydrocortisone acetate from different commercial formulations].
    Neubert RH; Pötzsch A
    Pharmazie; 2004 Jun; 59(6):472-4. PubMed ID: 15248463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
    Boddu SH; Bonam SP; Wei Y; Alexander K
    Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A method to measure the solubility of drugs in ointment bases.
    Kobayashi N; Saitoh I
    Chem Pharm Bull (Tokyo); 1998 Nov; 46(11):1833-5. PubMed ID: 9845962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone acetate encapsulation into Trojan particles.
    Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
    J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin.
    Jensen LB; Petersson K; Nielsen HM
    Eur J Pharm Biopharm; 2011 Sep; 79(1):68-75. PubMed ID: 21664463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro evaluations of water-absorption properties of various ointments.
    Mafune E; Takahashi M; Takasugi N
    Drug Dev Ind Pharm; 1998 Jan; 24(1):51-6. PubMed ID: 15605597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
    Felician WA; Ghaly ES
    Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On a new heparinoid ointment for general practitioners].
    GAERTNER W
    Med Monatsschr; 1963 Jan; 17():37. PubMed ID: 13946086
    [No Abstract]   [Full Text] [Related]  

  • 38. [ON THE TREATMENT OF THROMBOVARICOSE DISORDERS WITH A HEPARINOID OINTMENT].
    FISCHER M
    Wien Med Wochenschr; 1964 Dec; 114():904-7. PubMed ID: 14339569
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the permeability of corticosteroid in hairless mouse and hairless micropig skin from admixture of commercially available corticosteroid ointments and/or creams].
    Ohtani M; Kotaki H; Kariya S; Uchino K; Iga T
    Yakugaku Zasshi; 2002 Aug; 122(8):589-94. PubMed ID: 12187775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and in vitro evaluation of ofloxacin-ethocel controlled release matrix tablets prepared by wet granulation method: influence of co-excipients on drug release rates.
    Shah S; Shah K; Jan SU; Ahmad K; Rehman A; Hussain A; Khan GM
    Pak J Pharm Sci; 2011 Jul; 24(3):255-61. PubMed ID: 21715257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.